REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Paviour Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Paviour Pharmaceuticals Private Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Paviour Pharmaceuticals Private Limited is an unlisted company, incorporated on 01/09/1998. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL1998PTC095875 and registration number is 095875.

Headquarters
311-312 Suneja Tower I Distt Centre Janak Puri New Delhi Dl In New Delhi In-Dl In 110058
West Delhi; Delhi; Postal Code: 110058

Contact Details: Purchase the Paviour Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Paviour Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Paviour Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
September 01, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
32.26%
Purchase this report to view the information.
18.87%
Company Performance
Financial values in the chart are available after Paviour Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
27.53%▲
Total operating revenue
28.82%▲
Operating profit (EBIT)
28.93%▲
EBITDA
25.71%▲
Net Profit (Loss) for the Period
28.97%▲
Total assets
-16.09%▼
Total equity
10.04%▲
Operating Profit Margin (ROS)
0.03%▲
Net Profit Margin
0.01%▲
Return on Equity (ROE)
1.34%▲
Debt to Equity Ratio
-0.26%▼
Quick Ratio
0.5%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo